Abstract
A major obstacle to employing short complementary nucleic acid strands for modulating gene expression is the apparent randomness with which target mRNAs are inhibited (1). We have hypothesized that the inability to predict mRNA structure in vivo is a significant component of this problem because it is not known which regions of an mRNA molecule are accessible for basepairing or other recognition processes. A number of strategies have been developed to ask if a region of mRNA is single-stranded and free of bound protein, but all have their limitations. Accordingly, we have attempted to develop a different approach to this problem.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Opalinska JB, Gewirtz AM. Nucleic-acid therapeutics: basic principles and recent applications. Nat Rev Drug Discov 2002; 1(7):503–514.
Tyagi S, Bratu SP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nature Biotechnology 1998; 16:49–53.
Sokol DL, Zhang X, Gewirtz AM. Direct in vivo detection of hybridization between antisense oligodeoxynucleotides and target mRNA. Proc Natl Acad Sci USA 1998; 95:11,538–11,543.
Crooke ST. Advances in understanding the pharmacological properties of antisense oligonucleotides. Adv Pharmacol 1997; 40:1–49.
Lavignon M, et al. Inhibition of murine leukemia viruses by nuclease-resistant alpha-oligonucleotides. Antisense Res Dev 1992; 2(4):315–324.
Monia BP, et al. Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem 1993; 268(19):14514–14522.
Gewirtz AM, Stein CA, Glazer PM. Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proc Natl Acad Sci USA 1996; 93(8):3161–3163.
Dewanjee MK, et al. Kinetics of hybridization of mRNA of c-myc oncogene with Inlabeled antisense oligodeoxynucleotide probes by high-pressure liquid chromatography. Biotechniques 1994; 16(5):844–846,848,850.
Monia BP, et al. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. Proc Natl Acad Sci USA 1996; 93(26):15481–15484.
Sczakiel G, Homann M, Rittner K. Computer-aided search for effective antisense RNA target sequences of the human immunodeficiency virus type 1. Antisense Res Dev 1993; 3(1):45–52.
Milner N, Mir KU, Southern EM. Selecting effective antisense reagents on combinatorial oligonucleotide arrays [see comments]. Nat Biotechnol 1997; 15(6):537–541.
Sohail M, Southern EM. Selecting optimal antisense reagents. Adv Drug Deliv Rev 2000; 44(1):23–34.
Ho SP, et al. Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries [see comments]. Nat Biotechnol 1998; 16(1):59–63.
Scherr M, et al. RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts. Nucleic Acids Res 2000; 28(13):2455–2461.
Ho SP, et al. RNA mapping: selection of potent oligonucleotide sequences for antisense experiments. Methods Enzymol 2000; 314:168–183.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gifford, L.K., Lu, P., Gewirtz, A.M. (2004). Identification of Hybridization Accessible Sequence in Messenger RNA. In: Gewirtz, A.M. (eds) Nucleic Acid Therapeutics in Cancer. Cancer Drug Discovery and Development. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-777-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-59259-777-2_12
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9858-5
Online ISBN: 978-1-59259-777-2
eBook Packages: Springer Book Archive